文献速递血液透析通路

当代技术优化桡动脉-头静脉动静脉瘘手术的术中效果

Intraoperative Optimization of Radiocephalic Arteriovenous Fistula Surgery with Contemporary Techniques.
PubMed 文献 · Ann Vasc Surg · 2026-06-15

优化流程显著提高术中流量(210±89 vs 163±85 mL/min,P=0.008)和6周(77% vs 43%,P=0.002)及12周(91% vs 59%,P=0.003)成熟率,但12个月一期通畅率及人均干预次数无显著差异,且干预组人均费用显著更高(€5858.77 vs €4148.89,P=0.002)。

要点

  • 标准化术中流程可提高RCAVF术中流量和早期成熟率。
  • 优化流程未显著改善12个月一期通畅率或减少干预次数。
  • 干预组人均费用显著高于对照组,长期成本效益待明确。

核心结论

  • 优化RCAVF术中流程可改善术中流量和早期成熟率,但未显著改善12个月一期通畅率,且增加人均费用。

主要发现

  • 干预组术中流量为210±89 mL/min,对照组为163±85 mL/min,差异有统计学意义(P=0.008)。
  • 6周成熟率干预组77%,对照组43%(P=0.002);12周成熟率干预组91%,对照组59%(P=0.003)。
  • 男性总体成熟率高于女性(66% vs 38%,P=0.030)。
  • 12个月一期通畅率和人均干预次数无显著差异,优化组12个月辅助通畅率有更好趋势。
  • 干预组人均费用为€5858.77,对照组为€4148.89(P=0.002)。

关键数值与推荐

  • 成熟定义为静脉直径≥4 mm、流量≥500 mL/min且可触及震颤。

临床怎么用

  • 对RCAVF术中可考虑采用联合血流测量、罂粟碱和外支撑装置的标准化流程以促进早期成熟。
  • 需权衡早期成熟获益与人均费用增加,长期成本效益尚不明确。

局限性

  • 回顾性设计,样本量有限(干预组43例,对照组59例)。
  • 长期获益和成本效益尚未确定,需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This retrospective study assesses the impact of a standardized intraoperative procedure on radiocephalic arteriovenous fistula (RCAVF) outcomes, combining Transit Time Flow Measurement, papaverine administration, and an external support device. METHODS: Consecutive RCAVF patients were included at The Hague Medical Center between November 2021 and October 2024. Intraoperative flow rates, maturation rates, and (assisted) patency rates at 6 and 12 weeks, and 6 and 12 months were compared to a contemporary control group from the same center. Maturation was defined as a venous diameter ≥ 4 mm, a flow ≥ 500 mL/min, and a palpable thrill. The number of interventions and per-patient costs of interventions and procedures were also recorded and compared. RESULTS: The study compared 43 patients in the intervention group with 59 in a control group. The optimized procedure significantly improved intraoperative flow rates (210 ± 89 mL/min vs. 163 ± 85 mL/min, P = 0.008) and maturation rates at 6 weeks (77% vs. 43%, P = 0.002) and 12 weeks (91% vs. 59%, P = 0.003). Males showed higher overall maturation rates (66% vs. 38%, P = 0.030). However, no significant differences were found in primary patency at 12 months, nor in the average number of interventions per patient. There was a trend toward better assisted patency in the optimized procedure group at 12 months. The intervention group had significantly higher average costs per patient (€5858.77 vs. €4148.89, P = 0.002). CONCLUSION: The optimized RCAVF procedure enhances intraoperative flow and early maturation rates, with the most notable effects in the initial postoperative months. Further research is needed to determine the long-term benefits and cost-effectiveness.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. White NA, de Winter EP, Bulder RM, et al. Intraoperative Optimization of Radiocephalic Arteriovenous Fistula Surgery with Contemporary Techniques. Ann Vasc Surg. 2026. PMID: 42297347. doi:10.1016/j.avsg.2026.05.083

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。